Results 11 to 20 of about 1,809,346 (164)
Effect of Inactivated Poliovirus Vaccine Campaigns, Pakistan, 2014–2017
Pakistan began using inactivated poliovirus vaccine alongside oral vaccine in mass campaigns to accelerate eradication of wild-type poliovirus in 2014.
Nicholas C. Grassly +4 more
doaj +2 more sources
Background Poliomyelitis is an acute viral infection caused by poliovirus and transmitted via the fecal–oral route. The causative agent is one of the three serotypes of poliovirus (serotypes 1, 2, 3) that differ slightly in capsid protein.
Joanne Hassan +6 more
doaj +2 more sources
Given its enhanced genetic stability, novel oral poliovirus vaccine type 2 was deployed for type 2 poliovirus outbreak responses under World Health Organization Emergency Use Listing. We evaluated the safety profile of this vaccine.
Farrell A. Tobolowsky +6 more
doaj +2 more sources
Lessons from Vaccine-Related Poliovirus in Israel, UK and USA
Genetic variants of vaccine poliovirus type 2, imported from an unknown source, were detected in waste waters in Jerusalem, London and New York in early 2022.
T. Jacob John, Dhanya Dharmapalan
doaj +2 more sources
Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization Registry [PDF]
Individuals with primary immunodeficiency disorder may excrete poliovirus for extended periods and will constitute the only remaining reservoir of virus after eradication and withdrawal of oral poliovirus vaccine.
Grace Macklin +31 more
doaj +2 more sources
Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014–April 2016 [PDF]
In 2014, inactivated poliovirus vaccine (IPV) campaigns were implemented in Nigeria and Pakistan after clinical trials showed that IPV boosts intestinal immunity in children previously given oral poliovirus vaccine (OPV). We estimated the effect of these
George Shirreff +4 more
doaj +3 more sources
Comparative Randomized Study of Tolerability, Reactogenicity, Immunogenicity and Safety of the Vaccine «BiVac Polio» (Oral Poliovirus Vaccine Type 1,3) [PDF]
Through the use of trivalent oral poliovirus vaccine made from Sabin strains of types 1, 2, 3 (tOPV), outstanding success of Global polio eradication program has been achieved. Since 1999, wild polio virus type 2 does not circulate in the world.
Yu. H. Khapchaev +6 more
doaj +2 more sources
An Unusual Case of Vaccine-Associated Paralytic Poliomyelitis [PDF]
The present article reports a case involving an immunocompetent, previously well child who, despite two previous doses of inactivated poliovirus vaccine, developed severe flaccid paralysis consistent with polio after receiving oral polio vaccine.
S Desai +6 more
doaj +2 more sources
Rare adverse events associated with oral poliovirus vaccine in Brazil
Oral poliovirus vaccine (OPV) developed by A. Sabin has been effectively used to control poliomyelitis in Brazil, and the last case with the isolation of a wild poliovirus strain occurred in March 1989.
Friedrich F.
doaj +1 more source
Past and Present Vaccinations in Sweden. [PDF]
Acta Paediatrica, Volume 115, Issue 11, Page 2505-2510, November 2026.
Silfverdal SA.
europepmc +2 more sources

